22
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T26406 |
A 204
Antibiotic A-204,Antibiotic A204,A-204,Antibiotic A 204,A204 |
Others | Others |
A 204 is a polycyclic polyether monocarboxylic acid antibiotic isolated from fermentation of strain of Streptomyces albus. | |||
TP1686L |
JAG-1, scrambled TFA(402941-23-5 free base)
|
Others | Others |
JAG-1, scrambled TFA(402941-23-5 free base) 是 JAG-1(188-204) 的加扰序列。 | |||
T22379L |
NLX-204 hydrochloride(2170405-10-2 free base)
|
5-HT Receptor | GPCR/G Protein; Neuroscience |
NLX-204 hydrochloride(2170405-10-2 free base)是一种有效且选择性的 ERK1/2 磷酸化偏好 5-HT1A 受体激动剂 (pKi = 10.19)。 | |||
TP1293 |
Jagged-1 (188-204) TFA(219127-21-6 free base)
Jagged-1 (188-204) TFA |
Gamma-secretase | Neuroscience; Proteases/Proteasome; Stem Cells |
Jagged-1 (188-204) TFA(219127-21-6 free base) 是 JAG-1 蛋白的一个片段。 JAG-1 是 Notch 配体,是一种在皮肤中表达最明显的肽。 JAG-1 诱导表皮成熟。将淹没的角质形成细胞单层暴露于钙浓度升高的 JAG-1 会产生具有 loricrin 表达和 NF-alphaB 激活的分层。 | |||
T1266 |
Terfenadine
(±)-Terfenadine,特非那定,MDL-991 |
Apoptosis; Potassium Channel; 5-HT Receptor; Caspase; Na+/Ca2+ Exchanger; HER; AChR; Histamine Receptor | Angiogenesis; Apoptosis; GPCR/G Protein; Immunology/Inflammation; JAK/STAT signaling; Membrane transporter/Ion channel; Neuroscience; Proteases/Proteasome; Tyrosine Kinase/Adaptors |
Terfenadine ((±)-Terfenadine) 是一种hERG 开放通道抑制剂,IC50为 204 nM。它也是一种 H1 组胺受体拮抗剂,通过调节Ca2+稳态在黑素瘤细胞中起到有效的细胞凋亡诱导作用。 Terfenadine 诱导 ROS 依赖性细胞凋亡,同时激活Caspase-4,-2,-9。 | |||
T12460 |
PI3K/mTOR Inhibitor-1
|
PI3K | PI3K/Akt/mTOR signaling |
PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual inhibitor of PI3K/mTOR (PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ/mTOR with IC50s of 20/376/204/46/186 nM) | |||
T30600 |
BSJ-03-204
BSJ03204 |
Others | Others |
BSJ-03-204 is a selective Cdk4/6 degrader. | |||
T34591 |
Sdz 204-090
|
Others | Others |
Sdz 204-090 is a cyclic octapeptide analog of somatostatin. | |||
T27839 |
LK 204-545
LK-204-545,LK204-545 |
Others | Others |
LK 204-545 is a highly selective antagonist of beta1-adrenoceptor. | |||
T63756 |
BAY-204
|
Others | Others |
BAY-204 是 CSNK1α/δ 抑制剂,能够用于增殖性疾病的治疗。 | |||
T71877 |
GC-204
|
Others | Others |
GC-204 is a selective inhibitor of carbonic anhydrase ix (caix) | |||
TP1686 |
JAG-1, scrambled
|
||
This peptide is a scrambled sequence of JAG-1(188-204). | |||
T76023 |
Jagged-1 (188-204) (TFA)
|
||
Jagged-1 (188-204) TFA 是 JAG-1 蛋白的一个片段,具有Notch 激动剂活性。JAG-1 是一种在培养的和原发性多发性骨髓瘤 (MM) 细胞中高度表达的Notch 配体。JAG-1 诱导单核细胞衍生的人树突状细胞成熟。 | |||
T71424 |
VT-102 free base
|
Others | Others |
VT-102 is a TEAD Auto-palmitoylation inhibitor that Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. VT102 inhibited the firefly luciferase reporter dose-dependently and had no 204 effect on the Renilla luciferase reporter. | |||
T22379 |
NLX-204
|
Others | Others |
NLX-204 is a selective, potent agonist of ERK1/2 phosphorylation-preferring serotonin 5 HT1A receptor with pKi value of 10.19. | |||
T68934 |
VT101 free base
|
Others | Others |
VT101 is a TEAD Auto-palmitoylation inhibitor that Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. VT101 inhibited the firefly luciferase reporter dose-dependently and had no 204 effect on the Renilla luciferase reporter. | |||
TP1540 |
Jagged-1 (188-204)
Jagged-1 188-204 |
Gamma-secretase | Neuroscience; Proteases/Proteasome; Stem Cells |
Jagged-1 (188-204) 是 JAG-1 蛋白的一个片段。其中 JAG-1 能够诱导单核细胞衍生的人树突状细胞成熟,是一种在培养的和原发性多发性骨髓瘤细胞中高度表达的 Notch 配体。 | |||
T79562 |
Leucettinib-92
|
CDK | Cell Cycle/Checkpoint |
Leucettinib-92(化合物92)作为DYRK/CLK激酶家族的抑制剂,展现出对多种激酶具有不同程度的抑制活性,IC50s依次为CLK1 147 nM、CLK2 39 nM、CLK4 5.2 nM、CLK3 0.8 μM、DYRK1A 124 nM、DYRK1B 204 nM、DYRK2 0.16 μM、DYRK3 1.0 μM、DYRK4 0.52 μM、GSK3 2.78 μM。 | |||
T77923 |
BSJ-03-204 triTFA
|
CDK; PROTACs | Cell Cycle/Checkpoint; PROTAC |
BSJ-03-204 triTFA是一种融合了Cereblon配体和CDK配体的PROTAC,作为基于Palbociclib的、高效的CDK4/6双重降解剂,选择性地对CDK4/D1和CDK6/D1表现出26.9 nM和10.4 nM的IC50值。它不会引发IKZF1/3的降解,展现了潜在的抗癌活性。 | |||
T79587 |
hCA/VEGFR-2-IN-2
|
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
hCA/VEGFR-2-IN-2 (compound 8g) 是一种具有吲哚酮基苯磺酰胺结构的化合物,目标是癌症相关的hCA IX/XII 及VEGFR-2 的双重抑制剂。该化合物对VEGFR-2 表现出强效的抑制作用(IC50=204 nM),且对hCAs有高亲和力,Ki 值分别为 hCA IX 3.6 nM、hCA II 16.1 nM、hCA XII 16.7 nM 以及hCA I 75.3 nM。hCA/VEGFR-2-IN-2 还展现出针对过表达VEGFR-2 的乳腺癌细胞的抗增殖活性。 | |||
T81739 |
Multi-target kinase inhibitor 2
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Multi-target kinase inhibitor 2 (compound 5K) 作为一种multi-targeted kinase抑制剂,对EGFR、Her2、VEGFR2和CDK2酶表现出强效活性,IC50值在40至204 nM之间。此化合物对包括HepG2、HeLa、MDA-MB-231 和 MCF-7在内的多种细胞系均显示出显著的细胞毒性,其IC50值分别为41、57、51 和 59 μM。此外,Multi-target kinase inhibitor 2 还能诱导HepG2细胞发生周期阻滞和凋亡 (apoptosis)。 | |||
T83685 |
UFP101 TFA
|
||
UFP101是一种合成肽类物质,作为nociceptin受体的拮抗剂(Ki为0.06 nM,测试于表达人类受体的CHO细胞中)。它对nociceptin受体的选择性高于κ-opioid受体(Ki为204 nM,测试于表达大鼠受体的CHO细胞中)。UFP101能抑制表达于CHO细胞膜的nociceptin受体释放GTPγS(EC50为1.86 nM)。通过脑室内给药,UFP101(10 nmol/每只动物)能延长小鼠尾巴甩动试验中的尾巴撤回潜伏期。在由盲肠结扎和穿刺诱发的小鼠败血症模型中,UFP101(0.003、0.03及0.3 mg/kg)能提高生存率。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T35775 |
HT-2 Toxin-13C22
HT-2 Toxin-13C22 |
||
HT-2 toxin-13C22is intended for use as an internal standard for the quantification of HT-2 toxin by GC- or LC-MS. HT-2 toxin is a type A trichothecene mycotoxin and an active, deacetylated metabolite of the trichothecene mycotoxin T-2 toxin .1,2Like T-2 toxin, HT-2 toxin inhibits protein synthesis and cell proliferation in plants.2HT-2 toxin also reduces viability of HepG2, A549, HEp-2, Caco-2, A-204, U937, Jurkat, and RPMI-8226 cancer cells with IC50values ranging from 3.1 to 23 ng/ml and human... |